HomeResearch Collaboration and LicensingCareersContact Us Worldwide Latest News More Pick Up Contents Annual Report 2016 Careers Commitment to Life Therapeutic Antibodies Notice February 10, 2017 Requests for Expanded Access to Unapproved Drugs in the U.S. (66KB) May 12, 2015 Warning against "Phishing" e-mails using the name of Kyowa Hakko Kirin (105KB) To Page Top Sitemap Terms & Conditions of Use Privacy Policy

HomeResearch Collaboration and LicensingCareersContact Us Worldwide Home About Us Kyowa Hakko Kirin at a Glance About Us Print Text size view with small font size view with medium font size view with large font size Kyowa Hakko Kirin at a Glance Who we are Kyowa Hakko Kirin is a R&D-based pharmaceutical company with special strengths in biotechnology. The Kyowa Hakko Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies. Overview of Kyowa Hakko Kirin Our value “Commitment to Life” Our Business Fields Kyowa Hakko Kirin/ Ethical Drugs Kyowa Hakko Bio/ Bio-Chemicals Kyowa Medex/ Diagnostics FUJIFILM KYOWA KIRIN BIOLOGICS/ Biosimilars Our Business Strategy Kyowa Hakko Kirin will further strengthen competitiveness in Japan through our category-based strategy. Category-based strategy applies to following four disease area: Nephrology Oncology Immunology&Allergy Central Nervous System FY2016-2020 Mid-term Business Plan(1,694KB) Products Kyowa Hakko Kirin’s products are all produced using cutting-edge manufacturing technology and equipment and under our strict quality assurance system and in full compliance with global standards. Learn more about our Products Our Heritage Kyowa Hakko Kirin is a pharmaceutical company, formed from a combination of the depth of experience and strong business record of Kyowa Hakko and Kirin Pharma. View our History R&D Kyowa Hakko Kirin is working to discover and create new ways to improve wellness and treat disease with a special focus on: Oncology Nephrology Immunology and allergy Kyowa Hakko Kirin also undertakes drug discovery and try new approaches especially on: Therapeutic antibodies Small molecule drugs Nucleic acid drugs Learn more about our R&D Related Links: Therapeutic Antibodies Kyowa Hakko Kirin Investors Relations Current or prospective investors can find information on stock and Kyowa Hakko Kirin, corporate governance, financials, links to events and presentations. Investors website About Us Kyowa Hakko Kirin at a Glance Overview Vision, Mission & Values Commitment to Life Management Corporate Governance Worldwide Locations To Page Top Sitemap Terms & Conditions of Use Privacy Policy